Acute Exacerbation of Pleuroparenchymal Fibroelastosis Secondary to Allogenic Hematopoietic Stem Cell Transplantation

Intern Med. 2020 Nov 1;59(21):2737-2743. doi: 10.2169/internalmedicine.4995-20. Epub 2020 Jul 14.

Abstract

In this article, we report a case with pleuroparenchymal fibroelastosis (PPFE) following hematopoietic stem cell transplantation (HSCT) that developed acute respiratory failure with new bilateral ground glass opacity, which could not be explained by either a pulmonary infection, drug toxicity or extraparenchymal causes. Although combination therapy with multiple immunosuppressants was transiently effective, the patient died from a recurrent exacerbation. Autopsied lungs demonstrated diffuse alveolar damage superimposed on PPFE. There was no evidence of any coexisting interstitial pneumonia with the usual interstitial pneumonia (UIP) pattern. Our case suggests that acute exacerbation can occur in patients with post-HSCT PPFE, even when a coexisting UIP pattern is absent.

Keywords: acute exacerbation; autopsy; corticosteroid; diffuse alveolar damage; hematopoietic stem cell transplantation; pleuroparenchymal fibroelastosis.

Publication types

  • Case Reports

MeSH terms

  • Autopsy
  • Fatal Outcome
  • Hematopoietic Stem Cell Transplantation / adverse effects*
  • Humans
  • Lung Diseases, Interstitial / diagnosis
  • Lung Diseases, Interstitial / etiology*
  • Lung Diseases, Interstitial / physiopathology*
  • Male
  • Middle Aged
  • Parenchymal Tissue / physiopathology*
  • Postoperative Complications / etiology*
  • Postoperative Complications / physiopathology
  • Respiratory Distress Syndrome / diagnosis
  • Respiratory Distress Syndrome / etiology*
  • Respiratory Distress Syndrome / physiopathology*